Cargando…
Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels
INTRODUCTION: SGLT-2 inhibitors are shown to be nephroprotective, slowing progression of nonalcoholic steatohepatitis (NASH) in addition to improving glycemic control in patients with type 2 diabetes (T2D). To date, no real-life clinical data is available on the effect of SGLT-2 inhibitors on urine...
Autores principales: | Benjamin, Silas, Ramanjaneya, Manjunath, Butler, Alexandra E., Janjua, Imran, Paramba, Firjeeth, Palaki, Jafer, Kubaisi, Aisha Al, Chandra, Prem, Abdalhakam, Ibrahem, Massodi, Nasseer Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012067/ https://www.ncbi.nlm.nih.gov/pubmed/36994321 http://dx.doi.org/10.3389/fcdhc.2021.733693 |
Ejemplares similares
-
Hypophosphatemic Osteomalacia in a Young Adult
por: Paramba, Firjeeth, et al.
Publicado: (2021) -
The Effects of Dapagliflozin in Patients With Heart Failure Complicated With Type 2 Diabetes: A Meta-Analysis of Placebo-Controlled Randomized Trials
por: Zhai, Miaobo, et al.
Publicado: (2021) -
Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)
por: Kinguchi, Sho, et al.
Publicado: (2019) -
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58
por: Mosenzon, Ofri, et al.
Publicado: (2021) -
Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department
por: Paramba, Firjeeth C, et al.
Publicado: (2013)